OLIGONUKLEOTIDE MIT EINER PHOSPHORTRITHIOAT-INTERNUKLEOSID-VERKNÜPFUNG
European patent · EP3830102 · In force
Register entry
- Publication number
- EP3830102
- Application number
- EP19755294
- Kind
- European patent with effect for Switzerland and Liechtenstein
- Status
- In force
- Specification
- Granted
- Filed
- Jul 30, 2019
- Published
- Jun 9, 2021
- Granted
- Jun 8, 2022
- Protection ends at the latest
- Jul 29, 2039
- Next annual fee due
- Jul 31, 2027
- IPC classes
- C07H 21/00 (2006.01)A61P 7/00 (2006.01)A61P 9/00 (2006.01)
- Priority
- EP 18186679 31.07.2018
- PCT application
- PCT/EP2019/070406 30.07.2019
- PCT publication
- WO2020/025563 06.02.2020
- Filing language
- English
- Source
- Swissreg
History
What the Federal Institute of Intellectual Property published about this title, newest first.
- Aug 1, 2026
Next annual fee due on
- Next annual fee due on
- 31.07.2026 → 31.07.2027
Published in Swissreg on 01.08.2026
- Aug 1, 2025
Next annual fee due on
- Next annual fee due on
- 31.07.2025 → 31.07.2026
Published in Swissreg on 01.08.2025
- Feb 21, 2025
Holder’s address changed
- Owner
- Roche Innovation Center Copenhagen A/S, Fremtidsvej 3, 2970 Hørsholm, Denmark → RICC A/S, c/o Roche Diagnostics A/S, Flaskehalsen 17, 4., 1799 Kobenhavn V, Denmark
Published in Swissreg on 21.02.2025
- Aug 1, 2024
Change
Published in Swissreg on 01.08.2024
- Aug 1, 2023
Change
Published in Swissreg on 01.08.2023
- Apr 19, 2023
Change
Published in Swissreg on 19.04.2023
- Aug 1, 2022
Change
Published in Swissreg on 01.08.2022
- Jun 8, 2022
Granted
Published in Swissreg on 08.06.2022
Parties
Inventor
The register names each party by name and address. A holder or agent is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.